Items Tagged ‘Lucemyra’

May 24, 2018

FDA Approves First non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults

By

Encouraging more widespread innovation and development of safe and effective treatments for opioid use disorder remains top agency priority The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults. While Lucemyra may lessen the severity of withdrawal symptoms, it may […]

View full entry

Tags: General, lofexidine hydrochloride, Lucemyra, News, opiod addiction, Opiod withdrawl, Other News Topics (not Types of Cancer)